{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T04:04:21Z","timestamp":1747109061341,"version":"3.40.5"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:p>Breast cancer patients commonly present to their OBGYN during the process of diagnosis and treatment of breast cancer both for specific gynecologic needs and for primary care follow up. These patients require counseling on contraception, hormone use, and fertility at diagnosis. During treatment and survivorship, patients will face a variety of side effects from treatments leading to vasomotor symptoms, vulvovaginal discomfort, sexual dysfunction, osteoporosis, and vaginal bleeding. This chapters aims to enlighten providers on the unique range of issues a gynecologist may face when caring for breast cancer patients.<\/jats:p>","DOI":"10.1097\/grf.0000000000000727","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T17:01:42Z","timestamp":1655398902000},"page":"494-509","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Management of Breast Cancer Survivors by Gynecologists"],"prefix":"10.1097","volume":"65","author":[{"given":"KATHRYN J.","family":"HUBER-KEENER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"R1-20250512","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3322\/caac.21565","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R2-20250512","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.3390\/cancers13194735","article-title":"Decisional regret in female oncofertility decision making\u2014an integrative narrative review","volume":"13","author":"Gon\u00e7alves","year":"2021","journal-title":"Cancers"},{"key":"R3-20250512","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1002\/cncr.29181","article-title":"Infertility in reproductive-age female cancer survivors","volume":"121","author":"Levine","year":"2015","journal-title":"Cancer"},{"key":"R4-20250512","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.fertnstert.2013.08.012","article-title":"Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion","volume":"100","year":"2013","journal-title":"Fertil Steril"},{"key":"R5-20250512","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1200\/JCO.2018.78.0858","article-title":"Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data","volume":"36","author":"Lambertini","year":"2018","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R6-20250512","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/GME.0000000000000440","article-title":"Prognostic impact of chemotherapy-induced amenorrhea on premenopausal breast cancer: a meta-analysis of the literature","volume":"22","author":"Zhou","year":"2015","journal-title":"Menopause N Y N"},{"key":"R7-20250512","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.breast.2015.10.003","article-title":"Contraception counseling for young breast cancer patients: a practical needs assessment and a survey among medical oncologists","volume":"30","author":"G\u00fcth","year":"2016","journal-title":"Breast Edinb Scotl"},{"key":"R8-20250512","first-page":"6419","article-title":"Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis","volume":"7","author":"Fu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"R9-20250512","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12885-015-1026-2","article-title":"Weight and weight change following breast cancer: evidence from a prospective, population-based, breast cancer cohort study","volume":"15","author":"Vagenas","year":"2015","journal-title":"BMC Cancer"},{"key":"R10-20250512","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2147\/JMDH.S117362","article-title":"Optimizing post-acute care in breast cancer survivors: a rehabilitation perspective","volume":"10","author":"Amatya","year":"2017","journal-title":"J Multidiscip Healthc"},{"key":"R11-20250512","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/era.12.178","article-title":"Breast irradiation and lactation: a review","volume":"13","author":"Leal","year":"2013","journal-title":"Expert Rev Anticancer Ther"},{"key":"R12-20250512","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.2017.76.2369","article-title":"Gaps in receipt of clinically indicated genetic counseling after diagnosis of breast cancer","volume":"36","author":"Katz","year":"2018","journal-title":"J Clin Oncol"},{"key":"R13-20250512","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/GRF.0000000000000521","article-title":"When should prophylactic oophorectomy be recommended at the time of elective hysterectomy?","volume":"63","author":"Huber-Keener","year":"2020","journal-title":"Clin Obstet Gynecol"},{"key":"R15-20250512","doi-asserted-by":"crossref","first-page":"100869","DOI":"10.1016\/j.yfrne.2020.100869","article-title":"Neuropsychiatric effects of tamoxifen: challenges and opportunities","volume":"59","author":"Novick","year":"2020","journal-title":"Front Neuroendocrinol"},{"key":"R16-20250512","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1002\/cncr.24508","article-title":"Tamoxifen treatment and risk of deep venous thrombosis and pulmonary embolism","volume":"115","author":"Hernandez","year":"2009","journal-title":"Cancer"},{"key":"R17-20250512","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.breast.2021.04.009","article-title":"A novel algorithm to reduce VTE in peri-operative patients on tamoxifen","volume":"58","author":"Nicola","year":"2021","journal-title":"Breast"},{"key":"R18-20250512","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/01.AOG.0000450757.18294.cf","article-title":"Committee Opinion No. 601: tamoxifen and uterine cancer","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"key":"R19-20250512","first-page":"86","article-title":"The effects of tamoxifen therapy on the endometrium","volume":"21","author":"Zarbo","year":"2000","journal-title":"Eur J Gynaecol Oncol"},{"key":"R20-20250512","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1200\/JCO.2002.20.11.2758","article-title":"Association of tamoxifen and uterine sarcoma","volume":"20","author":"Wickerham","year":"2002","journal-title":"J Clin Oncol"},{"key":"R21-20250512","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1102\/1470-7330.2008.0020","article-title":"The effect of tamoxifen on the genital tract","volume":"8","author":"Polin","year":"2008","journal-title":"Cancer Imaging"},{"key":"R22-20250512","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0002-9378(98)70315-1","article-title":"Abnormalities detected on transvaginal ultrasonography in tamoxifen-treated postmenopausal breast cancer patients may represent endometrial cystic atrophy","volume":"178","author":"McGonigle","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R23-20250512","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/(SICI)1097-0339(199812)19:6<417::AID-DC3>3.0.CO;2-P","article-title":"Effects of tamoxifen on the cytology of the uterine cervix in breast cancer patients","volume":"19","author":"Gill","year":"1998","journal-title":"Diagn Cytopathol"},{"key":"R24-20250512","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1200\/OP.20.00113","article-title":"Management of aromatase inhibitor-induced musculoskeletal symptoms","volume":"16","author":"Gupta","year":"2020","journal-title":"JCO Oncol Pract"},{"key":"R25-20250512","first-page":"1673","article-title":"Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: a systematic review and meta-analysis","volume":"25","author":"Beckw\u00e9e","year":"2017","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"R26-20250512","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(17)30715-5","article-title":"Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial","volume":"19","author":"Colleoni","year":"2018","journal-title":"Lancet Oncol"},{"key":"R27-20250512","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.clbc.2017.05.008","article-title":"Vaginal atrophy in breast cancer survivors: attitude and approaches among oncologists","volume":"17","author":"Biglia","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"R28-20250512","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpobgyn.2022.01.013","article-title":"Gynecological management of the breast cancer survivor","author":"Abel","year":"2022","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R29-20250512","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1016\/j.clbc.2021.10.003","article-title":"Time to update evidence-based guideline recommendations about concurrent tamoxifen and antidepressant use? A systematic review","volume":"22","author":"Bradbury","year":"2022","journal-title":"Clin Breast Cancer"},{"key":"R30-20250512","doi-asserted-by":"crossref","first-page":"2515690X19829380","DOI":"10.1177\/2515690X19829380","article-title":"Complementary and alternative medicine for menopause","volume":"24","author":"Johnson","year":"2019","journal-title":"J Evid-Based Integr Med"},{"key":"R31-20250512","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000501193","article-title":"Use of complementary and alternative medicine among young patients with breast cancer","volume":"15","author":"Hammersen","year":"2020","journal-title":"Breast Care"},{"key":"R32-20250512","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.2014.60.7366","article-title":"A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial","volume":"33","author":"Goetsch","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R33-20250512","first-page":"311","article-title":"A single-arm, prospective trial investigating the effectiveness of a non-hormonal vaginal moisturizer containing hyaluronic acid in postmenopausal cancer survivors","volume":"29","author":"Carter","year":"2021","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"R34-20250512","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s00520-017-3960-9","article-title":"Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance)","volume":"26","author":"Barton","year":"2018","journal-title":"Support Care Cancer"},{"key":"R35-20250512","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.maturitas.2020.06.021","article-title":"No increase in incidence or risk of recurrence of breast cancer in ospemifene-treated patients with vulvovaginal atrophy (VVA)","volume":"142","author":"Cai","year":"2020","journal-title":"Maturitas"},{"key":"R36-20250512","doi-asserted-by":"crossref","DOI":"10.19080\/JGWH.2019.13.555871","article-title":"Safety and efficacy of ospemifene in women with a history of breast cancer","volume":"13","author":"Bruyniks","year":"2019","journal-title":"J Gynecol Womens Health"},{"key":"R37-20250512","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0378-5122(92)90246-Z","article-title":"Low-dose oestradiol in the treatment of urogenital oestrogen deficiency\u2014a pharmacokinetic and pharmacodynamic study","volume":"15","author":"Nilsson","year":"1992","journal-title":"Maturitas"},{"key":"R38-20250512","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/13697137.2014.947254","article-title":"Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels","volume":"18","author":"Santen","year":"2015","journal-title":"Climacteric J Int Menopause Soc"},{"key":"R39-20250512","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/GME.0000000000000956","article-title":"Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women\u2019s Health Initiative Observational Study","volume":"25","author":"Crandall","year":"2018","journal-title":"Menopause"},{"key":"R40-20250512","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10549-014-2930-x","article-title":"Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(\u00ae)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study","volume":"145","author":"Donders","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R41-20250512","first-page":"187","article-title":"Changes in serum estradiol levels with Estring in postmenopausal women with breast cancer treated with aromatase inhibitors","volume":"29","author":"Streff","year":"2021","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"R42-20250512","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/cmt.6.1.45.52","article-title":"A cohort study of topical vaginal estrogen therapy in women previously treated for breast cancer","volume":"6","author":"Dew","year":"2003","journal-title":"Climacteric J Int Menopause Soc"},{"key":"R43-20250512","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/jnci\/93.10.754","article-title":"Hormone replacement therapy after a diagnosis of breast cancer in relation to recurrence and mortality","volume":"93","author":"O\u2019Meara","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"R44-20250512","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-0-387-78818-0_2","article-title":"Adaptation to estradiol deprivation causes up-regulation of growth factor pathways and hypersensitivity to estradiol in breast cancer cells","volume":"630","author":"Santen","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"R45-20250512","first-page":"CD003382","article-title":"Strategies for managing sexual dysfunction induced by antidepressant medication","volume":"5","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"R46-20250512","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/00004714-199906000-00012","article-title":"Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors","volume":"19","author":"Land\u00e9n","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"R47-20250512","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/jamainternmed.2015.8565","article-title":"Efficacy and safety of flibanserin for the treatment of hypoactive sexual desire disorder in women: a systematic review and meta-analysis","volume":"176","author":"Jaspers","year":"2016","journal-title":"JAMA Intern Med"},{"key":"R48-20250512","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/AOG.0000000000003325","article-title":"Female Sexual Dysfunction: ACOG Practice Bulletin Summary, NUMBER 213","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"suppl 1","key":"R49-20250512","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/713847125","article-title":"Randomized, placebo-controlled, double blind, crossover design trial of the efficacy and safety of Zestra for Women in women with and without female sexual arousal disorder","volume":"29","author":"Ferguson","year":"2003","journal-title":"J Sex Marital Ther"},{"key":"R50-20250512","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1200\/JCO.1999.17.8.2365","article-title":"Risk of menopause during the first year after breast cancer diagnosis","volume":"17","author":"Goodwin","year":"1999","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R51-20250512","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.fertnstert.2015.11.020","article-title":"Menses resumption after cancer treatment-induced amenorrhea occurs early or not at all","volume":"105","author":"Jacobson","year":"2016","journal-title":"Fertil Steril"},{"issue":"suppl","key":"R52-20250512","doi-asserted-by":"crossref","first-page":"TPS596","DOI":"10.1200\/JCO.2018.36.15_suppl.TPS596","article-title":"POSITIVE (IBCSG 48-14\/BIG 8-13\/A221405): evaluating outcomes after interrupting endocrine therapy (ET) for women with endocrine responsive (ER+) early breast cancer (BC) who desire pregnancy","volume":"36","author":"Partridge","year":"2018","journal-title":"J Clin Oncol"},{"key":"R53-20250512","first-page":"74","article-title":"Safety of pregnancy following breast cancer diagnosis: a meta-analysis of 14 studies","volume":"47","author":"Azim","year":"2011","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"R54-20250512","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/cancers13051070","article-title":"Time to pregnancy, obstetrical and neonatal outcomes after breast cancer: a study from the Maternity Network for Young Breast Cancer Patients","volume":"13","author":"Labrosse","year":"2021","journal-title":"Cancers"},{"key":"R55-20250512","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1200\/JCO.2012.45.6335","article-title":"Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study","volume":"31","author":"Amant","year":"2013","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"R56-20250512","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1200\/JCO.2007.11.9081","article-title":"Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study","volume":"26","author":"Schaapveld","year":"2008","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"suppl 3","key":"R57-20250512","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.6004\/jnccn.2013.0215","article-title":"NCCN Task Force Report: bone health in cancer care","volume":"11","author":"Gralow","year":"2013","journal-title":"J Natl Compr Cancer Netw JNCCN"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000727","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:12:31Z","timestamp":1747062751000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GRF.0000000000000727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000727","relation":{},"ISSN":["0009-9201"],"issn-type":[{"type":"print","value":"0009-9201"}],"subject":[],"published":{"date-parts":[[2022,6,16]]}}}